Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO timing after autologous stem cell transplantation in newly diagnosed multiple myeloma
ChiCTR1800017025Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Mar 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of recombinant human thrombopoietin in multiple myeloma (MM) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Hematopoietic recovery time. Started Mar 2014; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on ChiCTR1800017025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017025.